Aussie boss roasted on LinkedIn

The new Australian CEO of GSK Luke Miels yesterday brazenly unveiled a three-year costing-saving program just six months into the job, but it was his much more low-key announcement to relocate the company's R&D headquarters, that has sparked a fierce response on LinkedIn.

GSK said it would establish a new flagship R&D Centre on the UK's Cambridge Biomedical Campus, closing its historic R&D hub in Stevenage.

Miels said he'd started exploring a move to Cambridge when he took the top job in January, saying it would allow the company to be "fully immersed" in the UK's life sciences ecosystem.